Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
What does Teva's growth strategy look like?
Teva reaches $4.25 billion settlement over alleged role in opioid crisis - CBS News
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva, one of the biggest generic makers, joins the the brand-name club
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to court | US News | Sky News
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - KTSA
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva profit plummets, stock slides | Ctech
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva weighs potential sale of its $2B API business: reports
